Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal ...

As part of its ongoing RAK diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the LINK between diabetes and kidney disease, shedding light on the prevention ...

November is Diabetes Awareness Month and the chronic disease remains one of the most common in the United States.

As part of its ongoing RAK Diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the ...

The FDA rejected sotagliflozin 5 years ago for the same indication but for the broader population of adults with T1D, due to ...

A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Sernova’s technology helped type 1 diabetes patients achieve insulin independence in early- and mid-stage trials.

November is Eye Disease Month, and there’s a serious condition of the eye that is a leading cause of blindness in people who ...

Off-label SGLT2 inhibitors increase the risk of euglycemic diabetic ketoacidosis. GLP-1RAs may lead to rapid weight loss in ...